The independent relationship between both miRNAs and leptin or adiponectin warrants new studies to further examine the contribution of other unexplored adipokines attributed to secondary lymphedema to improve the understanding of the pathophysiology that leads to the condition, thereby contributing to the development of a tool that can assess the risk of lymphedema in breast cancer survivors. This evidence concerns the gene LEP and breast cancer.